U

University of Michigan | Kellogg Eye Center

Research site
(Unclaimed)
Location
24 Frank Lloyd Wright Drive, Lobby G/Suite 1500, Ann Arbor, Michigan, United States of America

Site insights

Top conditions

Top treatments

NT-501
Zimura
Lidocaine
Linsitinib

Parent organization

This site is a part of University of Michigan

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 20 total trials

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) (LIDS)

The overall objective is to study the safety, pharmacokinetics and efficacy of linsitinib (a small molecule IGF-1R inhibitor) administered orally twi...

Active, not recruiting
Thyroid Diseases
Graves Ophthalmopathy
Drug: Placebo
Drug: Linsitinib

The study consists of a randomized double-masked, placebo-controlled, parallel-group, multicenter trial with an optional open-label treatment period...

Enrolling
Thyroid Eye Disease
Other: Placebo
Biological: Teprotumumab

The purpose of this study is to evaluate the safety and efficacy of avacincaptad pegol intravitreal injection compared to Sham in participants with a...

Active, not recruiting
Stargardt's Macular Dystrophy
Drug: Sham
Drug: avacincaptad pegol

Trial sponsors

University of Michigan logo
M
N
Amgen logo
Astellas logo
Ipsen logo
J
S
Spark Therapeutics logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems